Shareholders meeting

Date: September 16, 2026 Ref:- GHL/2026-27/EXCH/54 The General Manager The Manager Dept. of Corporate Services Listing Department BSE Limited, National Stock Exchange of India Limited P J Towers, Dalal Street, Exchange Plaza, C-1, Block G, Mumbai - 400 001 Bandra Kurla Complex, Bandra (E), Mumbai - 400 051 Scrip Code: 543654 Symbol: MEDANTA Sub: Proceedings of the 22nd Annual General Meeting (‘AGM’) of Global Health Limited (‘The Company’) Dear Sir(s), Pursuant to the provisions of Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the proceedings of 22nd AGM of the Company are enclosed herewith as Exhibit. Kindly take the above on record. Thanking you, Yours faithfully For Global Health Limited Rahul Ranjan Company Secretary & Compliance Officer M. No. A17035 Encl: a/a Regd. Office: E-18, Defence Colony, New Delhi 110024, Ph No.011- 44114411 www.medanta.org, info@medanta.org, CIN: L85110DL2004PLC128319 Exhibit Summary of proceedings of 22nd Annual General Meeting held on September 16, 2026 at 12 Noon. The 22nd Annual General Meeting (AGM) of the Members of the Company was held on Wednesday, September 16, 2026 at 12 Noon, through Video Conferencing (VC)/Other Audio Visual Means (OAVM), in compliance with all the applicable provisions of the Companies Act, 2013 and the Rules made thereunder, read with various Circulars issued by the Ministry of Corporate Affairs and SEBI. The Company had provided remote e-voting facility to its Members to cast their votes electronically on all the resolutions set out in the Notice, which commenced on Saturday, September 12, 2026, 9.00 A.M. (IST) and ended on Tuesday, September 15, 2026, 5:00 P.M. (IST). Further, the Company had also provided e-voting facility to cast their votes during the AGM. Mr. Rahul Ranjan, Company Secretary welcomed all the Members and briefed them on the manner of participation in the meeting through VC/OAVM facility. He also apprised the Members that the Company had engaged the services of National Securities Depository Limited (NSDL), to enable them to attend the AGM proceedings through VC/OAVM. The facility for attending the AGM through Video Conferencing was made available at 11:30 A.M., i.e., 30 minutes before the scheduled commencement of the AGM, and remained available throughout the proceedings. Requisite quorum being present, the meeting was called to order. As required, all the requisite Statutory Registers and other documents, as mentioned in the AGM Notice were available during the AGM, for the inspection by the Members. Thereafter, the Company Secretary introduced given below Directors and officials present at the meeting: S. No. Name of Director/Official Designation 1. Dr. Naresh Trehan Chairman & Managing Director 2. Mr. Pankaj Sahni Group CEO & Director 3. Ms. Praveen Mahajan Independent Director 4. Mr. Rajan Bharti Mittal Independent Director 5. Dr. Ravi Gupta Independent Director Chairman - Audit Committee Chairman - Stakeholders Relationship Committee 6. Mr. Ravi Kant Jaipuria Non-Executive Nominee Director 7. Ms. Shonan Puri Trehan Non-Executive Director 8. Mr. Vikram Singh Mehta Independent Director Chairman – Nomination & Remuneration Committee 9. Mr. Yogesh Kumar Gupta Chief Financial Officer 10. Mr. Gaurav Chugh Head – Investor Relation Regd. Office: E-18, Defence Colony, New Delhi 110024, Ph No.011- 44114411 www.medanta.org, info@medanta.org, CIN: L85110DL2004PLC128319 The Company Secretary also informed the members that the representatives of Auditors of the Company were also present at the meeting. The Company Secretary requested Dr. Naresh Trehan, Chairman of the Board, to chair the Meeting. Dr. Naresh Trehan, Chairman, extended a warm welcome to all the Directors and Members present at the meeting. The Chairman opened the meeting by expressing heartfelt gratitude to all shareholders and stakeholders for their continued support. Thereafter, he outlined the Company's journey and growth in the light of Company`s commitment towards excellence in healthcare delivery and patient care. Thereafter, Mr. Pankaj Sahni, Group CEO & Director, updated the Shareholders on key financial & operational achievements of the Company in Financial Year 2025-26. He also thanked the Board of Directors for their invaluable guidance and all stakeholders for their unwavering support. The Notice convening the AGM was taken as read as the same was already circulated to the Members. The Chairman informed that there were no qualifications, observations or comments in the Auditors` Report on Financial Statements and Secretarial Audit Report for the Financial Year ended March 31, 2026. The following items as set out in the Notice of the 22nd AGM dated July 30, 2026, were transacted at the AGM: No. Resolutions Type of Resolution Ordinary Business(es) 1. To consider and adopt the Audited Standalone Financial Statements of Ordinary the Company for the financial year ended March 31, 2026, the Audited Consolidated Financial Statements for the financial year ended March 31, 2026 and the Reports of the Board of Directors and Auditors thereon. 2. To declare final dividend of ₹ 0.50/- per Equity Share for the financial Ordinary year ended March 31, 2026 3. To appoint a Director in place of Mr. Pankaj Sahni (DIN: 07132999) Ordinary who retires by rotation and being eligible, offers himself for re-election. Special Business(es) 4. To approve remuneration of M/s. Ramanath Iyer & Co., Cost Auditors Ordinary of the Company for Financial Year 2026-27. The Company had appointed M/s Mukesh Agarwal & Co., Company Secretaries, as the Scrutinizer for the purpose of scrutinizing the process of remote e-voting held prior to the AGM and e-voting during the AGM. On the invitation of the Chairman, the Moderator of the meeting invited the Shareholders who had registered themselves as Speakers, for their questions and clarifications. All the questions or clarifications sought were appropriately provided. Regd. Office: E-18, Defence Colony, New Delhi 110024, Ph No.011- 44114411 www.medanta.org, info@medanta.org, CIN: L85110DL2004PLC128319 Post the question-and-answer session, the Company Secretary informed the Shareholders that the consolidated voting results will be disseminated to the Stock Exchanges and will also be made available on the website of the Company at www.medanta.org and NDSL at www.evoting@nsdl.com on or before September 18, 2026. The Company Secretary thanked the Members and Directors for joining the meeting. The e-voting facility was kept open for the next 15 minutes to enable the Members to cast their vote, if not voted earlier. Upon completion of the e-voting process, the Meeting was concluded at 01:13 P.M. Regd. Office: E-18, Defence Colony, New Delhi 110024, Ph No.011- 44114411 www.medanta.org, info@medanta.org, CIN: L85110DL2004PLC128319